Página inicialPodcasts FDA Drug Safety PodcastsFDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)9 de fevereiro de 2022FDA Drug Safety PodcastsPlayOuvir episódio
